Patents by Inventor Phillip Comans

Phillip Comans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110311588
    Abstract: A method for prophylaxis or treatment of respiratory effort related arousals during sleep of a subject is provided. The method comprises administering to the subject an effective amount of an agent for reducing or inhibiting infection or colonisation of the nasal cavity of the subject by Staphylococcus aureus. Typically, the respiratory effort related arousal is associated with snoring. The agent may be selected from the group consisting of antibiotics, immunostimulants, probiotics and mixtures of the foregoing. A method for prophylaxis or treatment of snoring comprising administration of the agent to the subject is also provided.
    Type: Application
    Filed: November 9, 2009
    Publication date: December 22, 2011
    Inventor: Phillip Comans
  • Patent number: 7858073
    Abstract: There is described a method for selecting microbial isolates for use in oral killed vaccines against abnormal microbial colonization of mucosal surfaces by the microbes. The method comprises evaluating capacity of a plurality of different isolates of a microbe to activate antigen responsive cells to provide activation data for each microbial isolate, and the effectiveness of the isolates in reducing infection of a mucosal surface by the microbe to provide clearance data for each microbial isolate. An isolate, the activation data and clearance data for which correlate and is optimal for generating mucosal immunity against the microbe compared to the, or each, other of the isolates, or an isolate the activation data for which is optimal and a further isolate the clearance data for which is optimal, compared to the, or each, other of the isolates, respectively, is then selected for use in the vaccine.
    Type: Grant
    Filed: August 17, 2005
    Date of Patent: December 28, 2010
    Assignee: Hunter Technology Limited
    Inventors: Robert Clancy, Phillip Comans, Gerald Pang
  • Publication number: 20080112979
    Abstract: There is described a method for selecting microbial isolates for use in oral killed vaccines against abnormal microbial colonisation of mucosal surfaces by the microbes. The method comprises evaluating capacity of a plurality of different isolates of a microbe to activate antigen responsive cells to provide activation data for each microbial isolate, and the effectiveness of the isolates in reducing infection of a mucosal surface by the microbe to provide clearance data for each microbial isolate. An isolate, the activation data and clearance data for which correlate and is optimal for generating mucosal immunity against the microbe compared to the, or each, other of the isolates, or an isolate the activation data for which is optimal and a further isolate the clearance data for which is optimal, compared to the, or each, other of the isolates, respectively, is then selected for use in the vaccine.
    Type: Application
    Filed: August 17, 2005
    Publication date: May 15, 2008
    Applicant: Hunter Immunology Limited
    Inventors: Robert Clancy, Phillip Comans, Gerald Pang
  • Publication number: 20070269376
    Abstract: There is disclosed a method for determining an administration regimen for an oral killed vaccine for use in immunising individuals in a population against an infection or disease. The method comprise administering the oral killed vaccine to one or more individuals in a population and identifying an indicative dosaging level of the vaccine which induces a reduction in immune system responsiveness to the vaccine in the one or more individuals. A further dosaging level that elicits an immune response in one or more individuals of the population without inducing the reduction in immune system responsiveness to the vaccine is then determined.
    Type: Application
    Filed: August 17, 2005
    Publication date: November 22, 2007
    Applicant: Hunter Immunology Limited
    Inventors: Robert Clancy, Phillip Comans, Gerald Pang